Abstract
We report a rare case of acute liver injury by daily exposure to small amounts of chloroform in non-alcoholic fatty liver disease (NAFLD) patient. The patient had been followed up in our hospital every 3 months. Although his alanine aminotransferase (ALT) levels were steady around 30 ~ 60 U/L until August 2014, ALT level was spontaneously increased to more than 1,000 U/L at the follow-up point in late August 2014. As he was diagnosed as acute liver injury by chloroform exposure, we withdrew him from the exposure of chloroform and treated him with 600 mg/day of ursodeoxycholic acid. Afterwards, his ALT level rapidly improved and normalized within 1 month. To verify the influences of chloroform exposure, we measured plasma chloroform levels by gas chromatography. Although plasma chloroform concentration was 7.1 ng/ml (normal range: < 0.2 ng/ml) at the time of liver injury, the concentration had decreased to 0.7 ng/ml by 1 month later. Despite the fact that he had put on a face mask to protect from aspiration of chloroform, liver injury still occurred in the present case. Chloroform has a high solubility for lipids and accumulation of lipids in the liver might become a risk factor for liver injury by chloroform.
Similar content being viewed by others
Abbreviations
- AST:
-
Aspartate aminotransferase
- ALT:
-
Alanine aminotransferase
- NAFLD:
-
Non-alcoholic fatty liver disease
- NASH:
-
Non-alcoholic steatohepatitis
- UDCA:
-
Ursodeoxycholic acid
References
Agency USEP. Toxicological review of chloroform. In: Din M, editor. EPA/635/R-01/001 Washington. DC; 2001.
Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.
Enomoto H, Ueno Y, Hiasa Y, et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2020;55:353–62.
Enomoto H, Ueno Y, Hiasa Y, et al. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. J Gastroenterol. 2021;56:158–67.
Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56:951–63.
Lionte C. Lethal complications after poisoning with chloroform–case report and literature review. Hum Exp Toxicol. 2010;29:615–22.
Fang C, Behr M, Xie F, et al. Mechanism of chloroform-induced renal toxicity: non-involvement of hepatic cytochrome P450-dependent metabolism. Toxicol Appl Pharmacol. 2008;227:48–55.
Mansuy D, Beaune P, Cresteil T, et al. Evidence for phosgene formation during liver microsomal oxidation of chloroform. Biochem Biophys Res Commun. 1977;79:513–7.
Cohen EN, Hood N. Application of low-temperature autoradiography to studies of the uptake and metabolism of volatile anesthetics in the mouse. Haloth Anesthesiol. 1969;31:553–9.
Jayaweera D, Islam S, Gunja N, et al. Chloroform ingestion causing severe gastrointestinal injury, hepatotoxicity and dermatitis confirmed with plasma chloroform concentrations. Clin Toxicol (Phila). 2017;55:147–50.
Kang YJ, Ahn J, Hwang YI. Acute liver injury in two workers exposed to chloroform in cleanrooms: a case report. Ann Occup Environ Med. 2014;26:49.
Hwang S, Won S, Lee S. Nonalcoholic fatty liver disease for the incidence of drug-induced liver injury. Clin Gastroenterol Hepatol. 2022;20:964–5.
Lammert C, Imler T, Teal E, et al. Patients with chronic liver disease suggestive of nonalcoholic fatty liver disease may be at higher risk for drug-induced liver injury. Clin Gastroenterol Hepatol. 2019;17:2814–5.
Acknowledgements
The authors thank prof. Akira Namera (Department of Forensic Medicine, Hiroshima university) for excellent technical advice, Kenji Yamamuro and Kimiaki Sumino (Osaka Occupational Health Service Center, Japan Industrial Safety and Health Association) for the measurement of serum chloroform concentration, and Dr. Grace Naswa Makokha for the proofreading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Suehiro, Y., Uchida, T., Tsuge, M. et al. Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report. Clin J Gastroenterol 16, 250–253 (2023). https://doi.org/10.1007/s12328-023-01760-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-023-01760-7